FindTrial
Sign In

Role of serum AMH levels (a blood test) in predicting successful ovulation (release of egg from ovary) among PCOS women undergoing ovulation induction treatment with tablet LETROZOLE.

Role of Anti-Mullerian hormone (AMH) levels in predicting ovulatory response among PCOS women undergoing ovulation induction with letrozole A Prospective cohort study. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/106989
Enrollment
167
Registered
2026-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Nil: Nil

Sponsors

Intramural Research Fund Committee JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: women diagnosed with PCOS by Rotterdam criteria aged 21-40 years

Exclusion criteria

Exclusion criteria: 1. Women with functional ovarian cyst 2. Associated endometriotic cyst 3. Smoking 4. Women on Oral contraceptive pills within 3 months 5. Women with history of Ovarian surgery 6. Chemotherapy/ Radiotherapy

Design outcomes

Primary

MeasureTime frame
Ovulatory response among PCOS women undergoing ovulation induction with letrozoleTimepoint: 2 years—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactMadhivani Subburayalu

Jawaharlal Institute of Postgraduate Medical Education and Research Puducherry.

drsujatharaman@gmail.com7598500890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026